JAK2阻害剤療法に対する持続性のメカニズムとしてのヘテロジメ JAK-STAT 活性化
Priya Koppikar1, Neha Bhagwat, Outi Kilpivaara
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.
Nature
|July 24, 2012
まとめ
骨髄増殖性腫瘍 (MPN) は,JAK2シグナリング再活性化によるJAK2阻害剤療法にもかかわらず持続します. JAK2の分解を促進する治療法は,MPN患者における耐性を克服する可能性がある.
科学分野:
- 血液学 ヘマトロジ
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
背景:
- JAK2とMPLの体内の変異は,骨髄増殖性腫瘍 (MPN) を誘発する.
- JAK2キナーゼ阻害剤は,MPNの標準治療法であり,症状を改善しますが,悪性クローンを排除しません.
- JAK2阻害にもかかわらずMPNクローン持続のメカニズムは明らかにする必要があります.
研究 の 目的:
- 慢性的なJAK2阻害下でMPN細胞がどのように持続するかを調査する.
- MPNにおけるJAK2阻害剤耐性の基礎となる分子メカニズムを特定する.
主な方法:
- JAK-STATシグナリング再活性化とJAK2ヘテロディメリゼーションの分析.
- 細胞系,ネズミモデル,およびJAK2阻害剤で治療された患者に関する研究.
- JAK2依存性を評価するためのRNA干渉と薬理学的アプローチ.
主要な成果:
- JAK2阻害剤の持続性は,JAK-STAT経路の再活性化と相関しています.
- JAK1またはTYK2とのJAK2の異体化により,トランスでのJAK2の活性化が可能になります.
- 持続的なMPN細胞は,JAK2タンパク質発現に依存し,阻害剤に対して再敏感化することがあります.
- JAK2分解療法が持続性のある細胞で有効性を示しています.
結論:
- MPNクローン持続は,他のJAKキナーゼとの異体化によるJAK2活性化によって媒介されます.
- JAK2分解をターゲットにすることは,MPNにおけるJAK2阻害剤に対する耐性を克服するための有望な戦略です.
関連する概念動画
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:22Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...